Residual Neuromuscular Block of Rocuronium in Chemotherapy Patients Under Sevoflurane Anesthesia
Status:
Not yet recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Chemotherapy causes motor nerve dysfunction and degeneration that may alter the response to
neuromuscular blocking drugs. To analyse the risk of residual neuromuscular block (RNMB)
induced by rocuronium given in standard doses to patients who undergo chemotherapy within
three months.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University